Competitor Profile: Tide

Competitor Profile: Tide



This report provides information and insights on Tide, including details of its business and geographical presence; comprehensive coverage of its products and services; a comparative assessment of its main competitors; information on its performance, including its open banking model; and its key events and milestones.

Founded in 2015, Tides principle activity is to provide mobile banking to small businesses in the UK. Tide is designed for time-poor business owners who wish to focus on their work rather than their banking needs. With the use of Tides API, customers can receive real-time digital accountancy services from a number of third-party providers.

Scope

- In November 2017, Tide started offering loans through Tide Credit.
- In June 2018, Tide began offering cash deposits.
- In November 2018 the company partnered with accountancy firm Xero.

Reasons to buy

- Gain insight into Tides business operations and key events in the companys history.
- Learn about its product portfolio and open banking model.
- Assess the competitive dynamics in the retail banking industry by comparing its performance against competitors.

Overview
Key Milestones
Benchmarking
Performance Highlights
Open Banking Model
Funding
Partner Merchants
Themes Under Focus
Products & Services
Significant Events
Key Employees
Appendix

Smoothened Homolog - Pipeline Review, H1 2020

Smoothened Homolog - Pipeline Review, H1 2020Smoothened Homolog (Protein Gx or SMO) pipeline Target constitutes close to 14 molecules. Out of which approximately 11 molecules are developed by companies and

USD 3500 View Report

Metabotropic Glutamate Receptor 4 - Pipeline Review, H1 2020

Metabotropic Glutamate Receptor 4 - Pipeline Review, H1 2020According to the recently published report Metabotropic Glutamate Receptor 4 Pipeline Review, H1 2020; Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4

USD 3500 View Report

Smoothened Homolog - Pipeline Review, H1 2020

Smoothened Homolog - Pipeline Review, H1 2020Smoothened Homolog (Protein Gx or SMO) pipeline Target constitutes close to 14 molecules. Out of which approximately 11 molecules are developed by companies and

USD 3500 View Report

Metabotropic Glutamate Receptor 4 - Pipeline Review, H1 2020

Metabotropic Glutamate Receptor 4 - Pipeline Review, H1 2020According to the recently published report Metabotropic Glutamate Receptor 4 Pipeline Review, H1 2020; Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4

USD 3500 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available